Chargement en cours...
The randomised clinical trial and the hazard ratio – medical research’s Emperor’s New Clothes?
As the enthusiasm for individualized treatment and targeted therapies continues to gain momentum, it seems timely to re-assess whether our current research tools are fit for purpose. Randomized Clinical Trials compare groups of patients, the Hazard Ratio is a ‘group summary statistic’, and modeling...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003285/ https://ncbi.nlm.nih.gov/pubmed/24731512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-260 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Chargement en cours...